 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.

Current Price	$3.38
Prev Close	$3.48
Open	$3.45
Dividend Yield	0.00%
50-Day Moving Average	$2.75
Beta	0.00
Avg. Volume	34,097.27
PE Ratio	-2.03

52-Week High	$7.51
52-Week Low	$1.39
Market Capitalization	$120.37M
EPS	-$1.66
Price to Book	0.99
Revenue Per Employee	$453,586.96
Enterprise Value/EBITDA	0.08

HOWL Werewolf Therapeutics Inc

About

Feed

Fundamentals

News